{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:06:25Z","timestamp":1793711185343,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,10,31]],"date-time":"2007-10-31T00:00:00Z","timestamp":1193788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00520-007-0341-9","type":"journal-article","created":{"date-parts":[[2007,10,30]],"date-time":"2007-10-30T02:04:56Z","timestamp":1193709896000},"page":"577-583","source":"Crossref","is-referenced-by-count":143,"title":["A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Helen G.","family":"Mar Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Chemerynsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Breunis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Braganza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Tannock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,31]]},"reference":[{"key":"341_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.2002.20.2.485","volume":"20","author":"TA Ahles","year":"2002","unstructured":"Ahles TA, Saykin AJ, Furstenberg CT et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long- term survivors of breast cancer and lymphoma. J Clin Oncol 20:485\u2013493","journal-title":"J Clin Oncol"},{"key":"341_CR2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1076\/jcen.20.3.339.822","volume":"20","author":"RH Benedict","year":"1998","unstructured":"Benedict RH, Zgaljardic DJ (1998) Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 20:339\u2013352","journal-title":"J Clin Exp Neuropsychol"},{"key":"341_CR3","first-page":"51","volume":"25","author":"AM Berger","year":"1998","unstructured":"Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25:51\u201362","journal-title":"Oncol Nurs Forum"},{"key":"341_CR4","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.38.10.1565","volume":"38","author":"ML Bleecker","year":"1988","unstructured":"Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J (1988) Age-specific norms for the Mini-Mental State Exam. Neurology 38:1565\u20131568","journal-title":"Neurology"},{"key":"341_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.21671","volume":"106","author":"JE Bower","year":"2006","unstructured":"Bower JE, Ganz PA, Desmond KA et al (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106:751\u2013758","journal-title":"Cancer"},{"key":"341_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archinte.161.3.411","volume":"161","author":"W Breitbart","year":"2001","unstructured":"Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J (2001) A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161:411\u2013420","journal-title":"Arch Intern Med"},{"key":"341_CR7","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1200\/JCO.2000.18.14.2695","volume":"18","author":"CB Brezden","year":"2000","unstructured":"Brezden CB, Phillips KA, Abdolell M et al (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695\u20132701","journal-title":"J Clin Oncol"},{"key":"341_CR8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.1998.16.5.1689","volume":"16","author":"JA Broeckel","year":"1998","unstructured":"Broeckel JA, Jacobsen PB, Horton J et al (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689\u20131696","journal-title":"J Clin Oncol"},{"key":"341_CR9","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1542\/peds.2004-2560","volume":"115","author":"RT Brown","year":"2005","unstructured":"Brown RT, Amler RW, Freeman WS et al (2005) Treatment of attention-deficit\/hyperactivity disorder: overview of the evidence. Pediatrics 115:e749\u2013757","journal-title":"Pediatrics"},{"key":"341_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0885-3924(89)90057-2","volume":"4","author":"E Bruera","year":"1989","unstructured":"Bruera E, Brenneis C, Paterson AH, MacDonald RN (1989) Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage 4:3\u20136","journal-title":"J Pain Symptom Manage"},{"key":"341_CR11","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1200\/JCO.2003.06.156","volume":"21","author":"E Bruera","year":"2003","unstructured":"Bruera E, Driver L, Barnes EA et al (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21:4439\u20134443","journal-title":"J Clin Oncol"},{"key":"341_CR12","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.2005.02.8506","volume":"24","author":"E Bruera","year":"2006","unstructured":"Bruera E, Valero V, Driver L et al (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073\u20132078","journal-title":"J Clin Oncol"},{"key":"341_CR13","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2007.10.9231","volume":"25","author":"E Bruera","year":"2007","unstructured":"Bruera E, El Osta B, Valero V et al (2007) Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 25:3475\u20133481","journal-title":"J Clin Oncol"},{"key":"341_CR14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570\u2013579","journal-title":"J Clin Oncol"},{"key":"341_CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S1041610291000728","volume":"3","author":"BS Fogel","year":"1991","unstructured":"Fogel BS (1991) The high sensitivity cognitive screen. Int Psychogeriatr 3:273\u2013288","journal-title":"Int Psychogeriatr"},{"key":"341_CR16","first-page":"57","volume":"2","author":"D Greene","year":"1994","unstructured":"Greene D, Nail LM, Fieler VK et al (1994) A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Pract 2:57\u201362","journal-title":"Cancer Pract"},{"key":"341_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1176\/appi.neuropsych.13.2.248","volume":"13","author":"CH Hinkin","year":"2001","unstructured":"Hinkin CH, Castellon SA, Hardy DJ et al (2001) Methylphenidate improves HIV-1-associated cognitive slowing. J Neuropsychiatry Clin Neurosci 13:248\u2013254","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"341_CR18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.1986.4.5.678","volume":"4","author":"MT Knobf","year":"1986","unstructured":"Knobf MT (1986) Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol 4:678\u2013684","journal-title":"J Clin Oncol"},{"key":"341_CR19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0895-4356(94)90122-8","volume":"47","author":"WA Kukull","year":"1994","unstructured":"Kukull WA, Larson EB, Teri L et al (1994) The mini-mental state examination score and the clinical diagnosis of dementia. J Clin Epidemiol 47:1061\u20131067","journal-title":"J Clin Epidemiol"},{"key":"341_CR20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.1998.16.4.1380","volume":"16","author":"C Lindley","year":"1998","unstructured":"Lindley C, Vasa S, Sawyer WT, Winer EP (1998) Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 16:1380\u20131387","journal-title":"J Clin Oncol"},{"key":"341_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0885-3924(98)00071-2","volume":"16","author":"AD Macleod","year":"1998","unstructured":"Macleod AD (1998) Methylphenidate in terminal depression. J Pain Symptom Manage 16:193\u2013198","journal-title":"J Pain Symptom Manage"},{"key":"341_CR22","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1200\/JCO.2005.01.6550","volume":"23","author":"HG Mar Fan","year":"2005","unstructured":"Mar Fan HG, Houede-Tchen N, Yi QL et al (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2\u00a0year follow-up of a prospective controlled study. J Clin Oncol 23:8025\u20138032","journal-title":"J Clin Oncol"},{"issue":"4","key":"341_CR23","first-page":"CD005001","volume":"18","author":"M Markes","year":"2006","unstructured":"Markes M, Brockow T, Resch KL (2006) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev Oct 18(4):CD005001","journal-title":"Cochrane Database Syst Rev Oct"},{"key":"341_CR24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/jnci\/93.12.892","volume":"93","author":"C McNeil","year":"2001","unstructured":"McNeil C (2001) Cancer fatigue: one drug fails but more are in the pipeline. J Natl Cancer Inst 93:892\u2013893","journal-title":"J Natl Cancer Inst"},{"key":"341_CR25","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.1998.16.7.2522","volume":"16","author":"CA Meyers","year":"1998","unstructured":"Meyers CA, Weitzner MA, Valentine AD, Levin VA (1998) Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16:2522\u20132527","journal-title":"J Clin Oncol"},{"key":"341_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3816\/CBC.2005.n.002","volume":"5","author":"JA O\u2019Shaughnessy","year":"2005","unstructured":"O\u2019Shaughnessy JA, Vukelja SJ, Holmes FA et al (2005) Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin Breast Cancer 5:439\u2013446","journal-title":"Clin Breast Cancer"},{"key":"341_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-004-2175-1","volume":"89","author":"JA Roscoe","year":"2005","unstructured":"Roscoe JA, Morrow GR, Hickok JT et al (2005) Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89:243\u2013249","journal-title":"Breast Cancer Res Treat"},{"key":"341_CR28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G","volume":"85","author":"SB Schagen","year":"1999","unstructured":"Schagen SB, van Dam FS, Muller MJ et al (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640\u2013650","journal-title":"Cancer"},{"key":"341_CR29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1076\/clin.13.3.348.1749","volume":"13","author":"AM Shapiro","year":"1999","unstructured":"Shapiro AM, Benedict RH, Schretlen D, Brandt J (1999) Construct and concurrent validity of the Hopkins verbal learning test-revised. Clin Neuropsychol 13:348\u2013358","journal-title":"Clin Neuropsychol"},{"key":"341_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1523-5394.1998.1998006013.x","volume":"6","author":"J Sitzia","year":"1998","unstructured":"Sitzia J, Huggins L (1998) Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Pract 6:13\u201321","journal-title":"Cancer Pract"},{"key":"341_CR31","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.2003.01.119","volume":"21","author":"N Tchen","year":"2003","unstructured":"Tchen N, Juffs HG, Downie FP et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175\u20134183","journal-title":"J Clin Oncol"},{"key":"341_CR32","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1200\/JCO.2001.19.6.1802","volume":"19","author":"SJ Thompson","year":"2001","unstructured":"Thompson SJ, Leigh L, Christensen R et al (2001) Immediate neurocognitive effects of methylphenidate on learning- impaired survivors of childhood cancer. J Clin Oncol 19:1802\u20131808","journal-title":"J Clin Oncol"},{"key":"341_CR33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnci\/90.3.210","volume":"90","author":"FS Dam van","year":"1998","unstructured":"van Dam FS, Schagen SB, Muller MJ et al (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210\u2013218","journal-title":"J Natl Cancer Inst"},{"key":"341_CR34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00520-006-0037-6","volume":"14","author":"J Vardy","year":"2006","unstructured":"Vardy J, Wong K, Yi QL et al (2006) Assessing cognitive function in cancer patients. Support Care Cancer 14:1111\u20131118","journal-title":"Support Care Cancer"},{"key":"341_CR35","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.20272","volume":"100","author":"JS Wefel","year":"2004","unstructured":"Wefel JS, Lenzi R, Theriault RL et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292\u20132299","journal-title":"Cancer"},{"key":"341_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pon.2960040108","volume":"4","author":"MH Wieneke","year":"1995","unstructured":"Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 4:61\u201366","journal-title":"Psycho-oncology"},{"key":"341_CR37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00365854","volume":"3","author":"MB Wilwerding","year":"1995","unstructured":"Wilwerding MB, Loprinzi CL, Mailliard JA et al (1995) A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer 3:135\u2013138","journal-title":"Support Care Cancer"},{"key":"341_CR38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0885-3924(94)90165-1","volume":"9","author":"JD Yee","year":"1994","unstructured":"Yee JD, Berde CB (1994) Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. J Pain Symptom Manage 9:122\u2013125","journal-title":"J Pain Symptom Manage"},{"key":"341_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K et al (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63\u201374","journal-title":"J Pain Symptom Manage"},{"key":"341_CR40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0341-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-007-0341-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-007-0341-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:01:44Z","timestamp":1559080904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-007-0341-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,31]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s00520-007-0341-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,31]]}}}